Gene · 5062
Papers2,274
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,274
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The dual roles of exosomes in prostate cancer: mechanisms in tumorigenesis and avenues for clinical translation. | Front Immunol | 2026 | 41756279 | PubTator, text mining | PubMed |
| Novel AI-Driven Precision Strategies in Diabetic Wound Healing: Immunomodulation and Advances in Smart Composite Nanocarriers. | Pharmaceutics | 2026 | 41754993 | PubTator, text mining | PubMed |
| METTL5-mediated m6A modification of 18S rRNA drives oral squamous cell carcinoma progression by enhancing CCND3 translation. | Oncol Lett | 2026 | 41743013 | PubTator, text mining | PubMed |
| Lactylation-based machine algorithm combined with multi-omics analysis to predict prognosis in cervical cancer. | Oncol Lett | 2026 | 41743011 | PubTator, text mining | PubMed |
| Antiviral drug discovery and development: challenges and future directions. | Signal Transduct Target Ther | 2026 | 41735249 | PubTator, text mining | PubMed |
| Exploratory whole-exome sequencing identifies candidate DNA variants in Ocular Behcet disease: a pilot study from a Pakistani cohort. | Ophthalmic Genet | 2026 | 41730713 | PubTator, text mining | PubMed |
| Mechanistic insights into hepatic metastasis of pancreatic cancer: molecular perspectives. | Transl Gastroenterol Hepatol | 2026 | 41675331 | PubTator, text mining | PubMed |
| Interruption of cross-communication pathways alters the immune cell signature of pancreatic cancer and decreases tumor growth. | Cell Commun Signal | 2026 | 41546097 | PubTator, text mining | PubMed |
| Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated Degradation. | bioRxiv | 2026 | 41542462 | PubTator, text mining | PubMed |
| The effects of LINC00324 on cell proliferation, migration, and invasion via autophagy in melanoma. | Sci Rep | 2026 | 41526496 | PubTator, text mining | PubMed |
| Role of serine/threonine phosphatases 1 and 2A in pancreatic acinar fluid and electrolyte secretion. | Am J Physiol Gastrointest Liver Physiol | 2026 | 41525767 | PubTator, text mining | PubMed |
| Brain vascular stability relies on PAK2-cilia-PDGF-BB-HSPGs on basolateral side of endothelium. | Life Sci Alliance | 2026 | 41490797 | PubTator, text mining | PubMed |
| Identification of the Dynamic Expression Patterns of Immune Genes in the Peripheral Blood of Acute Ischemic Stroke Patients. | Biochem Genet | 2026 | 41214317 | PubTator, text mining | PubMed |
| A Case of PAK2-Rearranged Malignant Hidroacanthoma Simplex Arising From a Pre-Existing Poroma. | J Dermatol | 2026 | 41195788 | PubTator, text mining | PubMed |
| Integrated proteomics and bioinformatics reveal the pharmacological mechanism of Shenqi Yanshen granule in chronic kidney disease-mineral and bone disorder (CKD-MBD). | J Ethnopharmacol | 2026 | 41067325 | PubTator, text mining | PubMed |
| Phosphoproteomic Analysis of CARMIL1 Reveals Novel Regulatory Mechanisms and Upstream Kinases Involved in Actin Dynamics and Cell Migration. | Cytoskeleton (Hoboken) | 2026 | 40521964 | PubTator, text mining | PubMed |
| Special Issue "Latest Review Papers in Molecular Oncology 2024". | Int J Mol Sci | 2025 | 41465263 | PubTator, text mining | PubMed |
| Molecular-Level Design Principles and Strategies of Peptide Self-Assembly Nanomaterials: From Sequence Engineering to Functional Applications. | Int J Nanomedicine | 2025 | 41438428 | PubTator, text mining | PubMed |
| PAK2 promotes CTC cluster formation by phosphorylating E-cadherin to enhance cell-cell adhesion in breast cancer. | Breast Cancer Res | 2025 | 41423632 | PubTator, text mining | PubMed |
| Nef stabilizes actin to prevent HIV-1 sensing by RIG-I-like receptors. | Nat Commun | 2025 | 41354661 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5062/papers?page=2